These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18290729)

  • 1. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and prevention of breast cancer.
    Welsh J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D metabolism in mammary gland and breast cancer.
    Welsh J
    Mol Cell Endocrinol; 2011 Dec; 347(1-2):55-60. PubMed ID: 21669251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
    J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells.
    Byrne B; Welsh J
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):703-7. PubMed ID: 17254776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
    Valrance ME; Welsh J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM; Welsh J
    Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of the vitamin D endocrine system in mammary gland and breast cancer.
    Welsh J
    Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin D receptor in cancer.
    Thorne J; Campbell MJ
    Proc Nutr Soc; 2008 May; 67(2):115-27. PubMed ID: 18412986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
    Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
    Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
    Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
    Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
    Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
    Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
    Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
    Keith ME; LaPorta E; Welsh J
    Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth.
    Ching S; Kashinkunti S; Niehaus MD; Zinser GM
    J Cell Biochem; 2011 Nov; 112(11):3393-405. PubMed ID: 21769914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling pathway in mammary gland development and carcinogenesis.
    Turashvili G; Bouchal J; Burkadze G; Kolar Z
    Pathobiology; 2006; 73(5):213-23. PubMed ID: 17314492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer.
    Narvaez CJ; Zinser G; Welsh J
    Steroids; 2001; 66(3-5):301-8. PubMed ID: 11179738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.